What's happening
This bill requires many public and private entities in New York to acquire, possess, and maintain opioid antagonists like naloxone for emergency overdose situations.
Why it matters
Expands readiness for opioid emergencies across society. By requiring a wide range of organizations—including schools, camps, government offices, community centers, shelters, correctional facilities, and even private entities like pharmacies—to keep opioid antagonists on hand, the bill addresses the widespread risk of opioid overdoses in diverse public and private spaces, not just medical settings.
Places operational and training responsibilities on institutions. Entities must not only acquire and maintain at least two doses of opioid antagonists, but also designate trained individuals responsible for their storage and oversight. This operationalizes overdose response, making it a formal part of institutional safety protocols.
Reduces barriers to access and liability. The bill allows for non-patient-specific prescriptions and clarifies that possessing and using opioid antagonists in accordance with the law does not violate professional practice statutes. This encourages broader participation in overdose prevention without fear of legal repercussions.
Recognizes but does not mandate individual intervention. While institutions are required to maintain opioid antagonists and have trained staff, there is no legal obligation for any individual to actually administer the medication, respecting personal choice and potential liability concerns.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Schools, colleges and summer camps
These institutions and covered employees would have to acquire and keep at least two provisions of an opioid antagonist and designate trained individuals to oversee storage and maintenance.
Ambulance services, police and fire stations, and correctional facilities
These entities would face mandatory opioid antagonist stocking requirements, but the bill would not require them to administer the medication.
Government offices, community centers and shelters
These sites and covered employees and contractors would be subject to possession requirements, with use on their behalf limited to trained individuals or those directed by a health care practitioner in a specific instance.
Pharmacies and authorized prescribers
The bill would allow non-patient-specific prescriptions for eligible people and entities, while also requiring pharmacies and doctors’ offices to stock opioid antagonists.
Headline styles
Require Naloxone in Public Places
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Require Naloxone at Key Sites
In Assembly Committee · Health · Sponsor Linda Rosenthal
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
9583
IN SENATE
May 16, 2024
Introduced by Sen. SEPULVEDA -- read twice and ordered printed, and when printed to be committed to the Committee on Health
AN ACT to amend the public health law, in relation to requiring certain eligible persons or entities to acquire and possess opioid antagonists
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. The public health law is amended by adding a new section 3000-f to read as follows:
§ 3000-f. Opioid antagonist. 1. Definitions. As used in this section:
(a) "Eligible person or entity" means (i) an ambulance service or advanced life support first response service; a certified first responder, emergency medical technician, or advanced emergency medical technician, who is employed by or an enrolled member of any such service; (ii) a children's overnight camp as defined in subdivision one of section thirteen hundred ninety-two of this chapter, a summer day camp as defined in subdivision two of section thirteen hundred ninety-two of this chapter, a traveling summer day camp as defined in subdivision three of section thirteen hundred ninety-two of this chapter; or a person employed by such a camp; (iii) a school district, board of cooperative educational services, county vocational education and extension board, charter school, non-public elementary and secondary school, colleges, and universities in this state; or any person employed by any such entity, or employed by a contractor of such an entity while performing services for the entity; (iv) a government office; an educational institution or after-school program; a community center; a publicly or privately operated shelter; or any person employed by any such entity, or employed by a contractor of such an entity while performing services for the entity; (v) a correctional facility, a county jail, a police station, or a fire station; a pharmacy, doctor's office; or any person employed by any such entity, or employed by a contractor of such an entity while performing services for the entity; and (vi) any other person or entity designated or approved, or in a category designated or approved pursuant to regulations of the commissioner in consultation with other appropriate agencies.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD06667-01-3
(b) "Opioid antagonist" means a drug approved by the Food and Drug Administration that, when administered, negates or neutralizes in whole or in part the pharmacological effects of an opioid in the body. "Opioid antagonist" shall be limited to naloxone and other medications approved by the department for such purpose.
(c) "Health care practitioner" means a health care practitioner licensed, certified, or authorized to practice under title eight of the education law who is authorized thereby to administer drugs, and who is acting within the scope of his or her practice.
2. Possession and use. (a) Any eligible person or entity shall acquire and possess and may use an opioid antagonist for emergency treatment of a person appearing to experience an opioid-related overdose.
(b) An eligible person or entity shall possess at least two provisions of an opioid antagonist at all times.
(c) An eligible person or entity shall designate one or more individuals who have completed the training required by paragraph (d) of this subdivision to be responsible for the storage, maintenance, control, and general oversight of the opioid antagonist acquired by the eligible person or entity.
(d) No one may use an opioid antagonist on behalf of an eligible person or entity unless he or she has successfully completed a training course in the use of opioid antagonists approved by the commissioner, or is directed in a specific instance to use an opioid antagonist by a health care practitioner.
(e) This section does not prohibit the use of an opioid antagonist (i) by a health care practitioner or (ii) by a person acting pursuant to a lawful patient-specific prescription.
(f) Every eligible person and entity authorized to possess and use an opioid antagonist pursuant to this section shall use, maintain and dispose of such antagonist pursuant to regulations of the department.
(g) Nothing in this section shall require any eligible person or entity to administer an opioid antagonist.
3. Prescriptions. (a) A health care practitioner who is authorized to prescribe drugs may prescribe, dispense or provide an opioid antagonist to or for an eligible person or entity by a non-patient-specific prescription.
(b) A pharmacist may dispense an opioid antagonist pursuant to a nonpatient-specific prescription under this subdivision.
(c) This subdivision does not limit any other authority a health care practitioner or pharmacist has to prescribe, dispense, provide or administer an opioid antagonist.
4. Application of other laws. (a) Use of an opioid antagonist pursuant to this section shall be considered first aid or emergency treatment for the purpose of any statute relating to liability.
(b) Purchase, acquisition, possession or use of an opioid antagonist pursuant to this section shall not constitute the unlawful practice of a profession or other violation under title eight of the education law or article thirty-three of this chapter.
(c) Any person otherwise authorized to sell or provide an opioid antagonist may sell or provide it to a person or entity authorized to possess it pursuant to this section.
§ 2. This act shall take effect on the one hundred twentieth day after it shall have become a law. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the public health law, in relation to requiring certain eligible persons or entities to acquire and possess opioid antagonists
Purpose
This bill requires certain eligible persons or entities to acquire and possess opioid antagonists.
Summary of provisions
Section one amends section 3000-e of the public health law.
Section five establishes the effective date.
Justification
The opioid epidemic has affected New Yorkers in every region of the state, and a growing body of research shows that public overdoses make up a large percentage of the overdose cases statewide. Opioid antag- onists like naloxone are increasingly available, allowing for trained administrators to reverse an overdose on the spot. Unfortunately, access to naloxone is still extremely limited, and establishments that might be able to offer lifesaving adnainistration of an opioid antag- onist are not required to have these drugs on site. With thousands of New Yorkers dying at the hands of this epidemic, it is essential that facilities across the state be required to carry, and have personnel trained in proper administration of, these lifesaving drugs.
This legislation requires that personnel at the following facilities statewide have a staff member trained in administration of an opioid antagonist and that at least two provisions of such opioid antagonist be on site at all times: ambulances or first response service providers, all public elementary and secondary schools, all non-public elementary and secondary schools, charter schools, universities, school districts or boards of education, children's overnight camps, government offices, after-school programs, community centers, publicly and privately oper- ated shelters, correctional facilities, county jails, police stations, fire stations, pharmacies and doctors' offices. This legislation sets forth a definition of opioid antagonist to mean any drug approved by the Food and Drug Administration that, when administered, negates or neutralizes the pharmacological effects of an opioid in the body.
Legislative history
2021-22: A.576 - Referred to Health
2019-20: A.448 - Referred to Health
2017-18: A.10187 - Referred to Health
Fiscal implications
Undetermined.
Effective date
This act shall take effect on the one hundred twentieth day after it shall have become a law.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.